REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,096,000 | +14.8% | 3,678,334 | +21.4% | 0.00% | – |
Q4 2021 | $955,000 | -55.5% | 3,030,213 | -2.4% | 0.00% | – |
Q3 2021 | $2,145,000 | -14.8% | 3,105,045 | +0.3% | 0.00% | – |
Q2 2021 | $2,517,000 | -49.9% | 3,095,237 | -3.9% | 0.00% | – |
Q1 2021 | $5,025,000 | +862.6% | 3,220,758 | +733.0% | 0.00% | – |
Q4 2020 | $522,000 | +866.7% | 386,659 | +266.7% | 0.00% | – |
Q3 2020 | $54,000 | +145.5% | 105,449 | +224.4% | 0.00% | – |
Q2 2020 | $22,000 | +46.7% | 32,503 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | -48.3% | 32,503 | 0.0% | 0.00% | – |
Q4 2019 | $29,000 | +26.1% | 32,503 | 0.0% | 0.00% | – |
Q3 2019 | $23,000 | -43.9% | 32,503 | 0.0% | 0.00% | – |
Q2 2019 | $41,000 | -6.8% | 32,503 | -25.4% | 0.00% | – |
Q1 2019 | $44,000 | -79.0% | 43,573 | -80.6% | 0.00% | – |
Q4 2018 | $210,000 | – | 225,178 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 1,985,472 | $3,097,000 | 1.60% |
Endurant Capital Management LP | 2,376,557 | $3,707,000 | 0.97% |
Sarissa Capital Management LP | 1,851,851 | $2,888,000 | 0.28% |
NEA Management Company, LLC | 6,451,056 | $10,064,000 | 0.23% |
Atom Investors LP | 337,228 | $526,000 | 0.09% |
Ikarian Capital, LLC | 1,245,989 | $1,943,000 | 0.06% |
GYL FINANCIAL SYNERGIES, LLC | 51,376 | $80,000 | 0.04% |
Focused Wealth Management, Inc | 100,000 | $156,000 | 0.03% |
Point72 Asset Management, L.P. | 3,215,436 | $5,016,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 141,629 | $221,000 | 0.01% |